Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New enzyme-based cardiovascular risk assessment test launched by the Mayo Clinic

April 11, 2003

NDA filed for Tracleer in Japan

April 10, 2003

SAR reported at ACS meeting in a series of ranolazine analogues

April 9, 2003

Improvement in metabolic syndrome upon chronic treatment with adenosine receptor antagonist

April 9, 2003

Chymase inhibitor shows potential in preventing aortic aneurysmal dilatation

April 9, 2003

DOV reacquires diltiazem rights from Biovail

April 7, 2003

Integrated pharmacokinetic/pharmacodynamic model developed for SB-480848

April 7, 2003

Orally available ACAT inhibitor described in Kowa patent

April 4, 2003

Pleiotropic cardiovascular effects of pitavastatin

April 4, 2003

Chimeric peptides show high potency in CHF in preclinical studies

April 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...